New pill may halt bone loss and damage
M1V-711 was tested against the patients given a placebo and those receiving the treatment showed a 65 per cent reduction in bone loss after six months with fewer side effects.
Oct 03, 2017, 15:03 PM IST
M1V-711 was tested against the patients given a placebo and those receiving the treatment showed a 65 per cent reduction in bone loss after six months with fewer side effects.
Oct 03, 2017, 15:03 PM IST